355 related articles for article (PubMed ID: 32704164)
1. Progress towards elimination goals for viral hepatitis.
Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
[TBL] [Abstract][Full Text] [Related]
2. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
Ward JW; Hinman AR
Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
[TBL] [Abstract][Full Text] [Related]
3. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
[TBL] [Abstract][Full Text] [Related]
4. Is Elimination of Hepatitis B and C a Pipe Dream or Reality?
Alter HJ; Chisari FV
Gastroenterology; 2019 Jan; 156(2):294-296. PubMed ID: 30593764
[No Abstract] [Full Text] [Related]
5. Research gaps in viral hepatitis.
Boyd A; Duchesne L; Lacombe K
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
[TBL] [Abstract][Full Text] [Related]
6. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
[TBL] [Abstract][Full Text] [Related]
7. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
Duffell EF; Hedrich D; Mardh O; Mozalevskis A
Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
[TBL] [Abstract][Full Text] [Related]
8. Global hepatitis C elimination: an investment framework.
Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
[TBL] [Abstract][Full Text] [Related]
9. Towards a hepatitis-free Egypt: is this achievable? (Editorial).
Doss W; Hermez J; Atta H; Jabbour J
East Mediterr Health J; 2018 Sep; 24(7):609-610. PubMed ID: 30370918
[TBL] [Abstract][Full Text] [Related]
10. New WHO guidance for country validation of viral hepatitis B and C elimination.
Easterbrook P; Luhmann N; Newman M; Walsh N; Lesi O; Doherty M
Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):778-780. PubMed ID: 34384530
[No Abstract] [Full Text] [Related]
11. Eliminating hepatitis from the Eastern Mediterranean Region.
Fikri M
East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128
[No Abstract] [Full Text] [Related]
12. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
[TBL] [Abstract][Full Text] [Related]
15. How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets.
García-Sepúlveda CA; Laguna-Meraz S; Panduro A
Ann Hepatol; 2020; 19(2):123-125. PubMed ID: 32138870
[TBL] [Abstract][Full Text] [Related]
16. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
17. Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019.
Alaama AS; Khattabi H; Mugisa B; Atta H; Hermez J; Hutin YJ
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):862-870. PubMed ID: 35817075
[TBL] [Abstract][Full Text] [Related]
18. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
19. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Palayew A; Razavi H; Hutchinson SJ; Cooke GS; Lazarus JV
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):948-953. PubMed ID: 32730784
[TBL] [Abstract][Full Text] [Related]
20. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
